Throughout May, Pharmaceutical Profiles is maintaining its focus on innovative clinical and pre-clinical protocols that support effective and efficient drug development...

Advanced Supercon, Inc. (ASCI), a new subsidiary of Bruker Corporation (NASDAQ: BRKR), announced that it has hired Thomas M. Rosa as Chief Financial Officer and Senior Vice President, and that it is establishing business development and customer support operations in the U.S...

CEMMNT the Centre of Excellence in Metrology for Micro and Nano Technologies, is pleased to announce the appointment of Paul Newbatt as its Business Development Director...

ICON plc (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced the appointments of Dr. Tom McCloskey as Associate Director, Cellular Immunology, Research and Development and Dr. Alamelu Chandrasekaran to the position of Manager, Molecular Diagnostics at ICON Central Laboratories...

UK-based Penn Pharmaceutical Services and Specials Clinical Manufacturing have entered into an innovative strategic alliance to provide outsourced services in sterile manufacturing, packing and distribution of investigational medicinal products (IMPs).

ISPE, a global not-for-profit association of 25,000 pharmaceutical science and manufacturing professionals, is partnering with a major American university for the first time to provide comprehensive, hands-on biotechnology training 12-14 May at North Carolina State University’s Golden LEAF Biomanufacturing Training and Education Center (BTEC) in Raleigh, North Carolina, USA.

The audit service provider blue inspection body GmbH, Germany, has strengthened its team of pharmaceutical inspectors by recruiting Dr. Wolfgang Heisig. blue inspection, which operates internationally on behalf of the pharmaceutical industry, checks whether active pharmaceutical ingredient manufacturers meet the requirements of Good Manufacturing Practice (GMP).

Image Solutions, Inc. (ISI), announced that world-leading global pharmaceutical group Boehringer Ingelheim has deployed eCTDXPress – the company’s flagship solution for managing and reviewing electronic submissions – via a Software-as-a-Service (SaaS) hosted model. The process from selection to implementation and validation took just under eight months.

Edinburgh based Big DNA Ltd, a spin out company launched late last year to commercialise a patented new vaccine technology, has appointed Lord Freeman as its chairman.